Hematopoetic stem cell transplantation for solid tumors in Europe

Gratwohl A., Baldomero H., Demirer T., Rosti G., Dini G., Ladenstein R., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.15, sa.4, ss.653-660, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 4
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1093/annonc/mdh142
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.653-660
  • Anahtar Kelimeler: donor type, Europe, hematopoetic stem cell transplants, solid tumors, transplant rates, HIGH-DOSE CHEMOTHERAPY, BONE-MARROW-TRANSPLANTATION, RISK BREAST-CANCER, RANDOMIZED-TRIAL, RESCUE, THERAPY, EBMT
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Hematopoetic stem cell transplants (HSCT) are discussed as treatment options for patients with solid tumors. Transplant numbers have changed substantially over the last decade, few controlled studies are available and different opinions prevail. Objective information on current practice is needed.